Stellar Biotechnologies – The real deal or just more tulip bulbs?

DISCLAIMER: I am long shares of SBOTF and may add to the position at any time.
”Even blind squirrels find an acorn every now and then”
OK, I know .. there is already plenty of discussion re Stellar Biotechnologies (SBOTF) on the site. Since Travis posted the tease from Nick Hodge in early July, the stock is up a hair over 100% (my Special Situation account sends many thanks for that one!). The reason I’m opening this thread is because the majority of comments from those of us interested or already invested in SBOTF are being posted under another wonderful – yet mostly unrelated – thread by Doc Gumshoe that talks about Alzheimers and possible causes/treatments/cures. Great stuff, but not fully germane to the topic of SBOTF. So, tho seperate the two discussions, I thought I’d try this so we can focus on each of the topics independantly.
That said, here’s some commentary about SBOTF that I have gleaned from the original tease, tracking the price action since July, reading member comments on this site, and studying anything and everything I can find about the Company and it’s product, Giant Keyhole Limpet Hemogobulin, a/k/a KLH.
First, a little peeve I’ve developed; the actual name of this animal that is the central focus of the business. I’ve noticed a trend of sorts by readers to refer to the Limpet as a ”snail”, ”escargot”, or something along those lines. While some may be using this as a light-hearted way of referring to the animal, it is not any of those. Please, use the proper name – as silly as it might sound. New readers could easily dismiss the entire idea and be misled otherwise. No disrespect meant to any who have done this, but I think it’s important we stay on track.
Now, some factoids for you.
If you haven’t done your due dilligence yet, the place to start is right here on this page. In the upper right you’ll see a box that says ”Teaser Tracking.” Click on that. The page that comes up is a list of the teases which Travis has posted over the past many months. Second from the top is the one re SBOTF. Some good tidbits of info right there. But what you want to do is look all the way over to the right and click on the link to the original tease posting. Open that and you’ll get the full story that Travis wrote when he first uncovered this tease (produced by Nick Hodge) and is a solid foundation of info about the company. Read it – two or three times to get an understanding of what SBOTF is all about.
Next, if you can find it, try and get a post that has the original video that Hodge did to tease the company with. In it, he (Hodge) interviews a couple of the company’s top executives and takes the cameras outside the room totalk with another employee about the ”farming” process that SBOTF has spent years and millions developing and patenting. You’ll get a pretty good visual inspection of the plant itself, the ”grow tanks”, and the Limpet. Good stuff. By the end you’ll have a fair overview of the company and what it does. FYI, the video tease runs about 40 minutes. It’s the first 25 minutes or so that will interest you. The remainder is what all teases consist of, overblown and repetitive pleas to get you to subscribe to the newsletter service that the promoter has to offer. Save yourself time and money by skipping that stuff.
A few takeaways from the video and additional research:
SBOTF has been around since the late 1990’s, working on how to extract the blood from the Limpet without killing them (they have done that and gotten patents on the process) and how to raise them in captivity in order to ensure a continuious supply of the animals to work with. This ”farming” process has, for the most part, been perfected and SBOTF can now raise them from fertilization of sperm and egg to maturity. They have a lifespan of some 30 years, and coupled with the patent-protected process they developed for extracting the blood without killing the Limpet, the company can now say with assurance that they can provide the Big Pharma with all the KLH they need to conduct clinical trials and produce the drugs they develop once FDA approval is granted. And – this is a big ”and” – they are the ONLY company in existence that can do this at the present time. The many patents they hold may ensure that to be the case for years to come.
Did I mention that KLH cannot be synthesized? So far nobody has been able to do that, so the supply of KLH from SBOTF seems to remain the only game in town.
Stellar Bio has yet to turn a profit. Sales and not much to write home about. That is mainly due to the small supply available and that SBOTF has focused on R&D in the past moreso than actual KLH production. That’s my best guess – I can’t verify that but seems to be the case. It is changing, however. The R&D is still in full swing, but the ability to produce and sell KLH is starting to ramp up as witnessed by increasing sales volume. It’ll take time but those increasing sales are coming.
In the wild (ocean floor), the Giant Keyhole Limpet has never been found ANYWHERE in the world other than in the small colony (estimated to be about 100,000 animals) which is just offshore from the Stellar Bio plant in Ventura County, CA. The enviromental community has been getting more and more concerned about the harvesting of the Limpets from this colony since there apparently aren’t any more around. Whisper talk about possible extinction have begun to surface, although no official governmental action regarding a ”protected specise” has yet been issued. This is why the farming of the animals has been crucial and why Stellar has such a leg up on any possible competition. If the Tree Huggers get hold of that idea, the ability to harvest the colony could – and probably would – be severely impacted.
Recent price and volume action has been fast and furious. As more and more people are becoming aware of the company by means of Hodges’ tease and thing such as this discussion, volume has had days that were near three times the average six months ago (175K shares average vs. some days now running around 500K). And most of this is upside volume indicating increasing demand for shares of a small float. This of course leads to highr prices as we are witnessing as I write.
For now, the gravy train is tearing down the track. The question is, when will demand for shares be curtailed as investor thirst for a bite of Limpet pie become satisfied? When will Nick Hodge back off this promotion, letting the press subside and therefore lessening investor awareness (the stock is not covered by any analyst, anywhere, that I can find, nor is it held by any mutual fund or investment management company). If and when this interest backs off, what effect will that have on the stock price? Trees don’t grow to the sky … or do they?
I can’t answer those questions. Just like you, I can only hold ’um and not fold ’um – yet. That day may come, and that is why I suggest anyone long the stock keep a DAILY eye on it. I’m making no prediction whatsoever about where the price will go over the next several weeks or months. In the interest of full disclosure, I have already taken some money off the table just to partially protect the quick profits I made since purchase. I sold about 30% of my initial position when that part became valued around 50% of my original investment. What remains is valued today right at the same $ amount I first put in. The amouunt I pulled out gives me full protection of some 50% of my original investment. Would I be better off today if I hadn’t done that? Yes. I would, because the price continues to rise. Will I be better of for having made thaat sale if the price stumbles and falls in the near future? Again, yes, I will – if the price falls. Some wise man once said ”you can’t go broke if you take profits” and I believe in that. Me, I don’t care for the idea of going broke, so I’m perfectly happy with this concept. No regrets about putting actual money in the bank, so to speak.
Comments? Concerns? Insights? Let the fun began!
Sincerely,
Your Resident Blind Squirrel
Jim Skelton

This is a discussion topic or guest posting submitted
by a Stock Gumshoe reader. The content has not been edited
or reviewed by Stock Gumshoe, and any opinions expressed
are those of the author alone.

The new guru of biotech on GumShoe does not think SBOTF is a good investment as he is not a KLH fan and sees it mostly failing in trials as a catalyst. I held out for a while and argued all the “long” points but he continued to research and does not like the long term prospects for Stellar. He knows a lot more about microbiology and medicine than I do so I got out several months ago and invested in BNIKF as my main microcap. Here’s another tip–if you can get in DRTX tomorrow morn–do so. It should go… Read more »

I’m still long SBOTF. It is already proven highly successful as a catalyst. Will one of the 20 trials it’s now involved with be successful. I dunno! But if it proves efficacious Dr. KSS believes someone will learn how to synthesize KLH. That might concern me if I was Stellar’s CEO, but not as an investor. No one will spend the time and money to try to develop it until KLH proves to have a large market. When KLH proves to have a big market, SBOTF will skyrocket. Also if KLH is used as a catalyst in a successful trial,… Read more »

Well, well, well, the last three days have seen a 41% jump, from $0.92 to $1.40, and on huge…35X average daily volume. I suspect this huge jump has something to do with Michael Robinson releasing a promotion to sell his Money Morning Prospectus, with a reference to “Living Metal”, which calls KLH something else and calls the Keyhole Limpet something else. Travis has that covered. here: http://www.stockgumshoe.com/reviews/radical-technology-profits/liquid-metal-tiny-company-has-monopoly-141478-for-a-thimbleful/ But there is also other news: Stellar to be listed on the major exchanges, several Big Pharma companies lining up to ink a deal with Stellar. A lot of this may be hype,… Read more »

Dayo22: I would be rather cautious at this point in time. I got out of Stellar a few months ago, just before it went down so badly. IMHO this one might go up a little while longer( how long I don’t know) but then it is time to come back down again. It has been heavily promoted again and after such promotions it does quite well. If there is real value to Stellar only time will tell, but it would take a couple of years to really find out. If you have this kind of time frame and determination to… Read more »

Dayo22, we have been fighting through old resistance in the $1.50 area; it seemed that every time we approached $1.50, we would get hit with massive selling, due, I suppose to overhead supply. Now, it certainly appears that all the people who needed to sell have sold, and we’ve broken through that resistance and are in the process of making a run at the previous high, about $2.30. I keep thinking: Holy cow! It can’t keep this up, and every day it keeps it up. I’ve rarely seen this kind of huge buy pressure. Last Friday, we hit $1.82, then… Read more »

Brad, Fred, Herbalix et al: Brad & Fred, glad to see you both had the fortitude to stick with this situation and are now reaping the gain – once again. And Herbalix, you acted in mostly the same way I did. Except I sold in April(?) around $0.93, bought back in on July 28th for $1.11, then sold August 18 for $1.57. I am currently out. I thought the effect of the newsletter promos had run their course. Not! It closed at $1.94 today! I urge caution at tis point. Will it run to the old highs around $2.30 (or… Read more »

Hi Jim; I’m pretty sure this volume is the partly result of Michael Robinson’s Living Metal promo, and I’ve suspected for some time that some big owner, perhaps that Ernesto fellow, and his private placement shares and warrants, but Stellar is trading HUGE volume…far too much for this to be simply a couple insiders manipulating the stock. the last couple weeks have seen like 2 million shares–35X average volume, when compared to that of the week preceding this run, when we were trading 35,000 shares per day. I’m really wondering if Stellar has news that they haven’t released; there are… Read more »

First. We’ve had some discussions on SG about following other’s advice. If its your money — its your call. Me. I’m sure this surge in price is the result of advertising from Money Map Press et al. Without the pumping or some other catalyst I don’t think the stock can hold $2.30. Of course if the stock is uplisted to the Nasdaq, that might provide a boost. They’ve been talking about that for quite a while. I like this company. Long term it MIGHT do well. It has a lot of irons in the fire and if it hits on… Read more »

OK, it’s time for us 17-year Stellar Locusts to wake up and start chirping again: If you’ll remember, last year about this time, Michael Robinson, of Money Map, released a promo about Stellar (calling KLH “Living Metal” and claiming that it was worth $150,000 for a thimbleful). Among the several things he was beating the drum about was Stellar’s imminent upgrade to the NASDAQ Index. I think we all kind of knew that wasn’t realistic, but (sigh!) hope springs eternal. Well, now Stellar IS making application to the NASDAQ! See: the Stellar website (http://www.stellarbiotechnologies.com), click on “Media”, then on “Press… Read more »

I’ve cashed in on this baby a couple of times, in the past, and am holding another–smaller–position, now. Starting June 14, 2016, it has put up a nice string of ten consecutive candles, establishing a clear uptrend. I found it especially interesting that on Friday, June 24, the day after Great Britain’s ‘Brexit’ vote, we jumped $0.61, a 16% jump, while worldwide markets swooned…the DOW fell 611 points. Although I was in favor of England leaving the European Union, and reclaiming its sovereignty from the over-reaching Eurocrats, I did read–and believed–that the move would involve some short term volatility. The… Read more »

Here we go, again: For the last couple days, we’re trading on 14X Volume, and as usual, I have no idea why; there is no particularly good news, recent earnings haven’t been…well, stellar. But we have posted a 30% gain, over the two days. Friday’s volume spike–going back to last Monday’s low–blasted us right through the Fibonacci Retracement zone, and in one fell swoop, snapped a long downtrend, and made Stellar a stock to Hold (Not Buy, not Sell…Hold). Monday’s follow through, on volume, made Stellar a Buy, with a bright short term, future. If this breakout proceeds as previous… Read more »

Well, again we find ourselves in another unforeseen Stellar low orbit rocket ride: from a low of $1.79, to an intraday high of $3.00, tn three days. A 68% jump for no reason that I can see. Stellar’s going to present at the LD Micro Main Event Investor Conference, in Los Angeles, on Pearl Harbor Day. So, I assume the goal is to find some Big Money investors to sell some cheap Private Placement shares to, which dilutes the value of the shares of us long suffering long term holders. I’ve asked Stellar why they didn’t give regular shareholders the… Read more »

Well, again, here we go; I just bought 4,000 shares a few days ago, after reading Yahoo’s take on Stellar’s prospects. We’ve had several ‘false starts’, but I’ve always thought that one day we’d take off and not fall back. I’ve also always thought that somebody is manipulating the heck out of this stock. And we just suffered another SPO of $5.5 million, and 1:7 Reverse split. I allowed the stock to fall a couple days and bought these shares in the $2.20 range. I don’t see any other posters; the only ones around here are the Crickets and me.… Read more »

Stansberry’s Teased Pick for “New Arms Race” to “Save the Internet”

Are 3.1 Million Electric Vehicles now Obsolete because of “1-1-8” Technology? Who’s the big Winner Teased by Casey’s Dave Forest?

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice.
Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all
authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.